[1]
Vo, V.N. et al. 2024. RESEARCH ON THE CLINICAL AND PARACLINICAL CHARACTERISTICS AND RESULTS OF DAPAGLIFLOZIN COMBINATION REGIMEN TREATMENT IN PATIENTS WITH CHRONIC HEART FAILURE MILDLY-REDUCED EJECTION FRACTION AT KIEN GIANG GENERAL HOSPITAL IN 2023–2024. Cantho Journal of Medicine and Pharmacy. 77 (Aug. 2024), 70–75. DOI:https://doi.org/10.58490/ctump.2024i77.2786.